MedTrace Logo

Therapeutical Assessment of Compression Armsleeves for Lymphatic Indications

NCT01318785 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-09-07

No results posted yet for this study

Summary

Examination of therapeutical effects of different types of armsleeves in treating lymphatic diseases after breast cancer surgery during maintenance phase

1. thesis:

\- all types should be equal regarding volume reduction
2. thesis: armsleeves manufactured with microfibre yarn are expected to be

* better in wearing comfort and
* better in handling features.

Conditions

  • Lymphedema

Interventions

OTHER

Compression Armsleeves

Type: Compression Class II (according to RAL) The study is designed in a way, that per product after a one weak resting (preparing) cycle a 2 weeks wearing period will follow. Herewith the whole duration of the study is 6 weeks per patient.

Sponsors & Collaborators

  • KABEG Management

    collaborator OTHER

  • Nij Smellinghe Hosptial

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Michael Jünger, Prof. Dr. · Klinik und Poliklinik für Hautkrankheiten der Universität Greifswald

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • Austria
  • Belgium
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318785 on ClinicalTrials.gov